Ionis Pharmaceuticals' shares are down more than 27% so far this year. What does Cathie Wood see that others are missing?

Rare-disease families can now invest in Mahzi Therapeutics' gene therapy, giving patients a financial stake in developing ...

The FDA says it can't license Regenative Lab's overseas sales today because it might change its regulations tomorrow. Now, ...

Months after axing its entire in-house sales, marketing and commercialization staff, Woburn-based Replimune is now slated for a third FDA review. The company had cut staff following the FDA’s second ...

A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

China’s nascent challenge has U.S. biotech startups hustling to emulate China’s efficiency and speed in drug development.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

The University of Pittsburgh announced an agreement with biotech company MitoSense Inc. to research opportunities in space ...

The two startups are the third and fourth, respectively, to outline offerings this month and aim to capitalize on momentum ...

Though funding totals represented the highest first-half sum since the start of 2022, industry watchers are concerned that ...

Another wave of layoffs has hit one of the Bay Area's biggest biotech companies—and the latest cuts push a troubling trend ...